Wird geladen...

Prognostication with circulating tumor DNA: is it ready for prime time?

Emerging methods to detect tumor-derived DNA in the blood plasma of patients with lymphomas—so-called “circulating tumor DNA” (ctDNA)—have the potential to change the way in which lymphoma is diagnosed and managed in the clinic. The possible applications for ctDNA are numerous, including mutation ge...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Hematology Am Soc Hematol Educ Program
1. Verfasser: Kurtz, David M.
Format: Artigo
Sprache:Inglês
Veröffentlicht: American Society of Hematology 2019
Schlagworte:
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6913479/
https://ncbi.nlm.nih.gov/pubmed/31808836
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/hematology.2019000013
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!